Replimune (REPL) Other financing activities (2018 - 2026)

Replimune has reported Other financing activities for 9 years, with the latest figure at $92000.0 in Q1 2026.

• Quarterly Other financing activities rose 187.5% year-over-year to $92000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $883000.0 (up 230.71% YoY) and the FY2026 annual result came in at $883000.0, up 230.71% from the prior year.
• Other financing activities retreated to $92000.0 in Q1 2026 per REPL's latest filing, from $791000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $89.6 million in Q1 2023 and troughed at -$48.3 million in Q4 2024.
• A 5-year average of $6.4 million and a median of $645500.0 in 2022 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 3911.58% in 2024, down 2845.45% in 2024.
• Over 5 years, Other financing activities stood at $500000.0 in 2022, then jumped by 251.6% to $1.8 million in 2023, then tumbled by 2845.45% to -$48.3 million in 2024, then surged by 101.64% to $791000.0 in 2025, then tumbled by 88.37% to $92000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $92000.0, $791000.0, and $32000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.